Much of how surgery is performed today is different than 10 or 20 years ago. Some of this change is distinctly radical (e.g., the introduction of laparoscopy, intraoperative imaging, robotics and other capital-intensive technologies), but much of the change is in a wide range of marginal changes in how surgeons manage, or manipulate, tissue, from the use of ablation technologies for the excision or destruction of tissue to the evolution of surgical securement products (wound closure and the use of products to prevent the formation of post-surgical adhesions).
The end result is that, as these new technologies take hold, they are effectively displacing or marginalizing technologies or techniques that have been the mainstay of surgery for a hundred years – the use the of the simple surgical scalpel, the performance of laparotomy (or “open” abdominal surgery) and the use of sutures (and even their more recent embodiment, staples) in wound closure. This shift in surgery is apparent in the different growth rates for surgical wound closure products markets (see chart), with sutures and mechanical wound closure markets eroding in the face of fibrin sealants, high strength glues and hemostasis products.
Surgical securement products are the subject of the October 2010 report #S180, “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015” from MedMarket Diligence.